SLEEP APNOEA & STRIDOR
DR. NEERAJ RAUNIYAR
MS ENT RESIDENT, 3rd
YEAR
GMSMA For ENT – H & N STUDIES
MMC, TUTH, IOM
SLEEP PHYSIOLOGY
 Sleep  temporary state of unconsciousness that can be interrupted by
external stimuli
 Stages of sleep
 Quiet/Non rapid eye movement sleep ( non-REM)
 Active/Rapid eye movement sleep (REM)
 Non-REM sleep
 4 stages
 Stage 1,2  EEG wave is low voltage & mixed frequency
 Stage 3,4  high voltage & slow frequency so caleed Slow Wave Sleep (SWS)
 Stage 2 account for ½ of adult sleep.
 REM speep
 Low voltage & high frequency
 2 pattern
 Tonic REM  depressed muscle tone
 Phasic REM  rapid eye movement & twitching of face & limbs
 Dream, increased autonomic activity, fluctuation in BP, pulse, RR  in sleep
 1st
REM occur  after 90 min of onset of sleep
 REM account 25% of sleep
 As sleep progresses REM increase & non-REM shortened
 Reticular activating system  promotes wakefulness when active &
promotes sleep when inactive.
 Neurotransmitters in sleep
 Amines
 Amino acids
 Peptides
 Melatonin  released in darkness & promotes sleep

SLEEP & RESPIRATION
 Respiratory centre  in medulla
 Afferent  central chemoreceptor
sensitive to ph
 Peripharal chemoreceptor sensitive to
P02
 Mechanoreceptor in airway, lungs &
chest wall
 Efferent  phrenic nerve, peripheral
nerve, respiratory muscle
 In non-Rem sleep  no diaphragmatic
activity & increased intercostal activity
 In REM sleep  increased
diaphragmatic activity & decreased
intercostal activity
 Reduction of metabolic rate by 10-25% during sleep due to inhibition of
motoe activity & decreased body temp.
 Upper airway muscle activity decreases during sleep with associated
increase in upper airway resistance predisposing to partial upper
airway obstruction
 Snoring  low frequency sound produced by vibration of upper airway
walls (esp. soft palate) during partial upper airway obstruction
SLEEP DISORDERS
 Respiratory sleep disorder
 Obstructive sleep apnoae/hypopnoae (OSAH)
 Central sleep apnoae/hypopnoae
 Cheyne- Stokrs breathing
 Sleep hypoventilation
 Non- respiratory sleep disorder
 Narcolepsy
 Periodic limb movement disorder
 Idiopathic hypersomnia
OBSTRUCTIVE SLEEP
APNOAE/HYPOPNOAE (OSAH)
 Recurrent episodes of partial or complete upper airway obstruction
during sleep which are usually terminated by an arousal
CAUSES
Congenital
 Nasal obstruction
 b/l choanal atresia
 Neonatal rhinitis
 Congenital cyst of nasal cavity
 Facial skeletal abnormalities
 Nasopharyngeal airway
obstruction
 Apert’s ,Crouzon’s syndrome
 Oropharyngeal obstruction
 Treacher Collins syndrome
 Pierre Robin syndrome
 Macroglossia
 Down’s syndrome, Beckwith
syndrome, cystic hygroma
 Pharyngeal swelling
 Lingual thyroid mass
 Lingual thyroglossal duct
 Cong tumors of pharynx
(teratoma, thorwald's cyst)
Acquired
 Traumatic
 Inflammatory
 Adenotonsillar hypertrophy
 Nasal polyp, rhinitis
 Peri/para/retropharyngeal abscess
 Neoplastic
 Angiofibroma, neuroblastoma,
lymphoma
 Iatrogenic
 Post tonsillectomy
adenoidectomy, PNP
 Pharyngeal airway dysfunction
 Obesity
 Pickwickian syndrome
 Chubby puffer syndrome (Stool
1997)
PATHOGENESIS
Sleep decreased upper airway muscle activity upper
airway collapse
Stimulate increased respiratory effort hypercapnia/ hypoxaemi
hypoventilation
Arousal resumption of normal upper airway muscle activity relief of
upper airway
obstruction
cycle repeats sleep resumes Correction of
hypercapnia/hypoxeamia
CONSEQUENCES OF OSAH
EPIDEMIOLOGY OF OSAH
 4 % male and 2% female ( Young et al,. 1993)
 Approx. 5% in a given population ( Young et al,. 2002)
 More common & severe in male
 3-7 yrs of age in children with equal in both sexes
 Greater in Chinese origin
 Risk factor for OSAH
 Obesity
 Gender ( male)
 Increased age
 Sex hormone ( progesterone  increases upper airway dilating muscle activity)
 Individual variation in mandibular, tongue & soft palate size and position
 Adenotonsillar hypertrophy
 Associated medical conditions:-
 Cardiovascular disease
 HTN
 CAD
 Cerebrovascular disease
 Stroke
 Metabolic syndrome
 Obesity
 DM
 HTN
 Insulin resistance
SYMPTOMS
 Snoring
 Fatigue
 Witnessed breath-holds
 Gasping & choking
 Excessive daytime
sleepiness (EDS)
 Fragmented sleep
• Unrefreshing sleep
• Reduced alertness
• Mood changes
• Nocturia
• Impaired work performance
• H/O DM, HTN, Hypertriglyceridaemai
In children
• Failure to thrive
• Sweet during sleep
• Unusual sleeping position
• Tracheal tug
• Hyperactivity Vs EDS in adult
EXAMINATION
 Central obesity
 BMI > 28
 Neck circumference > 47 cm (have predictive value)
 Detailed nasal & oropharyngeal examination including
 Mallampati score
 Retrognathia
 Craniofacial abnormality
 Adenotonsillar hypertrophy
 History & examination has sensitivity & specificity of 50% only (Hoffstein et al,.
1993)
 EDS measured with Epworth Sleepiness Scale (ESS) ???????put scoring table
THE EPWORTH SLEEPINESS SCALE
Score situation
 Sitting and reading
 Watching TV
 Sitting inactive in a public
place (eg, theater, meeting)
 As a passenger in a car for
an hour without break
 Lying down to rest in the
afternoon when
circumstances permit
 Sitting and talking to
someone
 Sitting quietly after a lunch
without alcohol
 In a car, while stopped for a
few minutes in the traffic
Normal score 2-10
Mod – severe OSA > 16
0 - Would never doze off
1 - Slight chance of dozing off
2 - Moderate chance of dozing off
3 - High chance of dozing off
INVESTIGATIONS
 Videondoscopy
 Polysomnography
 Sleep nasendoscopy +/- Video
 Oesopharyngeal manometry
 Cephalometry with Mueller manoeuver
 Fluroscopy
 3D CT
 Dynamic ultrafast MRI
 Acoustic analysis
 Nasal spray test
Can identify site of snoring
SLEEP NASENDOSCOPY-
 Can site of snoring be identified?
 Widely used in UK
 Procedure-:
Sleep Nasendoscopy Grading
Grade Obstruction
1 Simple palatal level snoring/palatal flutter
2 Single level palatal obstruction
3 Palatal level obstruction with intermittent
oropharyngeal involvement
4 Sustained multisegmental obstruction
5 Tongue base obstruction
6 Isolated epiglottic involvement
 Other way to classify level of obstruction is
 level 1  adenoid or valopharyngeal obstruction
 Level 2  tonsillar obstruction
 Level 3  tongue base obstruction
 Level 4  supraglottic obstruction
Fig Findings at sleep nasendoscopy.
The photographs show the endoscopic view of the
obstruction at each level from 1 to 4.
 Polysomnography
 EEG
 EOG
 EMG
 Overnight oximetry
 Domiciliary multichannel testing
 Apnoae  complete cessation of airflow for al least 10 sec. regardless of where there is
associated o2 desaturation or aurosal.
 In children its 6 sec duration
 Hypoapnoae  reduction in airflow of 50 – 90%with or without =/>3% o2 desaturation
&/or EEG changes OR reduction in airflow of <50% accompanied by =/>3% o2
desaturation &/or EEG changes
OVERNIGHT OXIMETRY
 Measure o2 saturation & pulse rate
 >97% SpO2  excludes hpoxia/ hpercarbia
 < 87% SpO2  coexistient cardiac or broncho-pulmonary disease
 Principle  when apnoea/hypoanoae 02 saturation falls & when
apnoae/hyponoae relieved o2 saturation recovered
 Rise & falls in 02 saturation  o2 dip
 A dip of fall in o2 saturation of 4%  significant
 O2 desaturation index (ODI)  no. of times of o2 saturation falls by 4%
averaged our per hr
 A ODI of > 15/hr OSA
 Other features in diagnosis of OSA are
 ESS > 10
 BMI > 28kg/m2
 Co-morbidities
 HTN
 CAD
 DM
 Metabolic syndrome
 O2 saturation monitored with wristwatch device which pt. wear at night
 It’s a screening tool which has good specificity but lack sensitivity
 It may miss OSA who do not desaturate
HOME MULTICHANNEL TESTING
 Usually consist of oronasal cannulae, thoracic &
abdominal band & finger oximeter probe
 Thoracic & abdominal band  determine type of upper
airway obstruction
 OSAH chest & abdominal band display movement
 Central Sleep apnoae/hypoapnoae  no chest &
abdominal movement
 Advantages-
 Pt. comfort
 Cost saving
 Prevention of hosp. admission
 Rapid analysis of data
 Disadvantages-
 Sensor failure
 Loss of signal
A classic example of OSA with repetitive apnoeas. X-axis is five
minutes.
1st
- trace is the oronasal cannulae flow, 2nd
- thoracic band,
3rd
- abdominal band, 4th
- trace is oxygenation and 5th
- is
pulse rate.
POLYSOMNOGRAPHY
 Gold standard
 Sleep state
 EEG
 EOG
 EMG
 Respiratory variables
 O2 saturation
 Oronasal airflow
 Chest & abd movement
 Tracheal microphone
 Oesophageal balloon
manometer
 Non respiratory variable
 ECG
 Anterior tibialis EMG
 Sleeping position detector
 Video monitoring
 Values calculated
 Apnea/hypoanoae index(AHI)
 Mild OSA = 5-20 / hour.
 Moderate OSA = 20-40 / hour.
 Severe OSA = >40 / per hour
 Apnea type
 Apnea duration
 Degree of O2 saturation
 Time spent at each level of desaturation
OVERNIGHT POLYSOMNOGRAPHY
 Indication-
 Complex OSA such as OHS
 Neuromuscular disorder which need ventilatory support
 Narcolepsy
 Periodic leg movement syndrome
OESOPHAGEAL MANOMETRY
 Used with sleep screening studies
 To diagnose apnoae/hypoapnoae
 Also used to evaluate relationship between reflux & OSA
C) Ultrafast MRI
 Used in awake and asleep pt.
 Also used to quantify surgical tissue volume resection to achieve resolution
of snoring
3D COMPUTERIZED TOMOGRAPHTY
 Esp. imp to evaluate retropalatal space
CEPHALOMETRY
 Esp for pt. undergoing UPPP & MAS
NASAL SPAY TEST
 Decongestant on alternate night compare severity of snoring &
apnoae
treat nasal pathology Improvement
in symptoms
 Which test should be used?
 Oximetry as 1st
line screening
 in borderline/ uncertain cases
PSG
 Apnoae/hypoapnoae index (AHI)  no. of apnoae/hypoapnoae
averaged per hr.
American Apnoae Association grading of sleep apnoae
AHI Level of OSA
< 5 No OSA
5-20 Mild
20-40 Moderate
> 40 Severe
TREATMENT
 When to treat?
 OSA without EDS &/or co-morbidity as HTN, DM, CAD  no treatment
Lifestyle modification like reducing wt. particularly if BMI > 25 kg/m2 & treating any
co-morbidity
 Mils OSA with EDS &/or co-morbidity as HTN, DM, CAD
 Moderate/ Severe OSA with/ without EDS & co-morbidity
 Treatment
 A) medical
 B) Surgical
Need treatment
 Medical management
 Exclude hypothyroidism/ acromegaly
 Alcohol advice
 Drug review
 Weight loss
 Nasal medication
 Nosovent
 Drugs
 Protryptyline
 Acetazolamide, theophylline, doxapram, buspirone, nocotine
MEDICAL TREATMENT
1.) Continuous positive airway pressure (CPAP)
 Acts as pneumatic splint
 MOA blowing air through a tube & mask through nasal &/or oral passageway
will support pharyngeal & palatal walls thus preventing collapse of airway
 The equipment
 Fixed pressure CPAP  constant blowing pressure
 Auto CPAP  vary pressure depending on presence of apnoae/hypoapnoae
 Predicted pressure for CPAP ( cm H2O)
= (0.16 x BMI) + ( 0.13 x NC) + (0.04 x AHI) -5.12
Where NC = neck circumference
Used in children who are syndromic, obese, CP
 S/E of CPAP
 Claustrophobia
 Nasal stuffiness
 Leaks
 Coryzal illness
 Skin abrasions
 Ulceration of bride of nose
 Air swallowing
 Pulmonary barotrauma
 Treatment Failure
 Mainly due to poor tolerance to CPAP
 Lead to continued symptoms + risk of co-morbidity esp. cardiovascular,
cerebrovascular & DM
 Compliance & Troubleshooting
 By 3 yr, 12-25%  discontinued CPAP
 Compliance increased  =/>4 hrs of using CPAP for at least 5 nights/weeks
 Close f/u
 Adequate education abt. CPAP
 Consequences of not treating OSA
Influence long-term use of CPAP
2.) Nasopharyngeal airway:-
 In new born & few days old baby
 Length adjusted acc. to site of obstruction
 e.g. in Pierre Robin sequence  lies just above epiglottis
 In Apart Syndrome  free edge of soft palate
3.) Mandibular Advancement Splint (MAS):-
 Not tolerate CPAP
 Not fit for surgery
NEW TREATMENT
 inspire® Upper Airway Stimulation (UAS) therapy is a new treatment
option for obstructive sleep apnea patients who are unable to use
Continuous Positive Airway Pressure (CPAP)
 Inspire is a fully implanted system that is designed to sense breathing
patterns and deliver mild stimulation to a patient’s airway muscles to
keep the airway open during sleep.
MULLER MANOEVER
Scoring system ( Sher et al 1985)
Degree of pharyngeal obstruction at each level
 1+ minimal collapse
 2+ collapse decreasing cross section area by 50%
 3+ collapse decreasing cross section area by 75%
 4 + obliteration of the airway
Soft palate level lower pharyng level UPPP
3+ 4+ - ideal
3+ 4+ 1+2+ suboptimal
<3+ > 2+ not suitable
 Indication for surgery:-
 Patient with severe antisocial snoring
 Without OSA
 Localized obstruction at one level in upper airway usually at palatal level
 Multisegmental obstruction with predominant obs. at palatal level
 Patient with mild-to-moderate sleep apnoae
 With severe antisocial snoring
 Failed or inadequate response to CPAP
 Localized obstruction at one level in upper airway usually at palatal level
 Patients with moderate-to-severe sleep apnoae
 With severe antisocial snoring
 Failed or inadequate response to CPAP
 Multisegmental obstruction
RFTVR
LAUP
UPPP
Combination of procedure on
Palate
Tongue base
Lateral pharyngeal walls
SURGICAL TREATMENT
 A) Adenotonsillectomy :
 Treatment of choice in children
 Treatment acc. To level of obstruction :-
 Level 1  adenoidectomy
 Level 2  tonsillectomy
 Level 3  nasopharyngeal airways, glossopexy, MAS, CPAP
 Level 4  LASER supraglottoplasty, anterior epiglottopexy
SURGICAL TECHNIQUE
 B) Uvulopalatopharyngoplasty
 Resection of a strip of soft palate & uvula in combination with tonsillectomy
 tonsillar pillar sutured together
 Principle to stiffen the soft palate by scarring and to increase space
behind the soft palate to minimize obstruction
 Complication:-
 Severe post-op pain
 Haemorrage (2-14%)
 Airway obstruction
 Post-op pulmonary oedema & hypoxia(2-11%)
 Nasal regurgitation (13%)
 valopharyngeal stenosis
 Dry throat
 Excessive pharyngeal hypersecretion (10%)
 Swallowing problems (9%)
 Voice changes (7%)
 Taste disturbance
 Short tern success rate  76-95%
 Long term success rate  45% (Hicklin et al,. 2000)
 C) Laser-assisted uvulopalatoplasty (LAUP)
 OPD procedure & done under local anaesthesia
 Principle  stiffen the soft palate and thereby minimize snoring due to palatal
flutter
 Procedure  Bilateral vertical incisions are made in the soft palate
followed by partial vaporization of the uvula with a CO2 laser after giving
local inj.
 Adv.  no post-op nasal regurgitation
 Disadv.  1-5 procedure 1 month apart to complete treatment
 Complication:-
 Comparatively less than UPPP bt depend on degree of vaporization
 Globus type sensation
 Post-op pain
 Fungal infection
 Short tern success rate  79%
 Long term success rate  55% (Berger et al,. 2001)
 D) Radiofrequency Tissue Volume Reduction (RFTVR)/ Thermal
ablation
 Principle  thermal injury to specific submucosal sites in the soft
palate resulting in fibrosis of the muscular layer and volumetric tissue
reduction
 Advantages:-
 Day care surgery under local
 Less post-op pain
 Less other complication
 Complications:-
 Ulcer of tongue base & soft palate
 Dysphagia
 Temporary CN XII palsy
 Abscess at tongue base
 Short tern success rate  50-85% (Johnson et al,. 2002)
 Long term success rate  52% (Said et al,. 2003)
 Recent advances in treatment in RFTVR
 Somnus device
 Celon device  bipolar electrode tip so reduced procedure time
 Coblater unit  larger electrode tip so more complication
NASAL OBSTRUCTION AND NASAL SURGERY IN THE
PATHOGENESIS AND TREATMENT OF SNORING AND
OBSTRUCTIVE SLEEP APNOEA
 Exact role unclear
 reduced nasal cross-sectional area promotes increased nasal
resistance to airflow and promotes inspiratory collapse of both the
oro­and hypopharynx
 If nasal obstruction contributes to OSA development, correction of
the obstructed airway should improve OSA but its not the case in
most of OSA
OCCASIONAL PROCEDURES FOR SNORING AND
OBSTRUCTIVE SLEEP APNOEA
 Injection snoroplasty technique
 Outpatient uvulopalatal flap
 Palatal inplants
 Repose tongue base suspension suture
 Mandibular Advancement Surgery (MVS)
 Brings tongue base forwards thus increasing dimension of upper airway
 Adv. 
 simplicity
 Reversibility
 Cost effectiveness
FOLLOW UP
 Aim to
 Determine compliance
 Minimize intolerance
 Improve symptoms
 Continue to modify cardiovascular risk factor
 Some centre uses repeat overnight oximetry with CPAP
CENTRAL SLEEP APNOEA
Causes
 Ondine’s curse
 Altitude
 Cheyne-Stokes respiration
 Congestive heart failure
 Myxoedema
 Neurological lesions
 Brainstem infarct, encephalitis
 Bulbar poliomyelitis
 Supratentorial space-occupying
lesions
Treatment
 Medical therapy
 Theophylline
 Ventilation via tracheostomy
 Diaphragm pacing with
implanted b/l phrenic nerve
electrodes
STRIDOR
 Stridor  noisy sound of high pitch generated from turbulence of airflow in
larynx & trachea.
 Stertor  low pitch snoring type of noise produced by
obstruction of naso & oropharynx
 Characteristics of stridor
 Inspiratory  extrathoracic obstruction from supraglottis
 Expiratory  obstruction in thoracic trachea or primary or
secondary bronchi
 Biphasic obstruction in glottis or subglottis or cervical trachea
 Bernoulli law – velocity increases, pressure decreases – collapse of airway
 Pascal’s principle – pressure same at every point on containing walls
Type of stridor n site of origin
CAUSES OF STRIDOR
Larynx
Congenital
1.Laryngomalacia
2.Subglottic stenosis
3.Webs, cyst, laryngocele
Inflammatory
4.Croup
5.Epiglottitis
6.Angioneurotic oedema
7.Diphtheria
8.Fungal infections
9.Tuberculosis
Vocal cord paralysis
1. Nerve damage, post
thyroidectomy
Trauma
2. Intubation
3. Neck trauma
4. FB
Neoplasam
5. Benign –subglottic hemangioma,
laryngeal papilloma, lymphangioma
6. Malignant – Ca larynx
Laryngospasm
Trachea & bronchi
Congenital
1. Vascular anomalies
2. Webs, cysts
3. Tracheal stenosis
4. Tracheoesophageal fistula
Inflammatory
5. Tracheitis
6. Bronchitis
7. Cruop
FB
1.Esophageal
2.Tracheal/bronchial
Neoplasm
3.Tracheal
4.Extraluminal
1.Thyroid
2.Esophageal
3.Thymus
Trauma
 Lesion outside respiratory tract
 Congenital: Vascular rings, oesophageal atresia, tracheo-
oesophageal fistula, cystic hygroma.
 Inflammatory: Retropharyngeal and retro-oesophageal abscess .
 Traumatic: FB oesophagus (secondary tracheal compresssion) .
 Tumours: Masses in neck
Age of onset Possible Aetiology
Birth Vocal cord paralysis choanal atresia, laryngeal web, vascular ring
4-6 weeks Laryngomalacia
1-4 years Croup, epiglottitis, foreign body aspiration
Chronicity
Acute Foreign body aspiration, croup, epiglottitis, retropharyngeal abscess
chronic Structural lesion laryngomalacia, laryngeal web or larynogotracheal stenosis
ASSESSMENT
Precipitating Factors Possible Aetiology
Worsening with straining or crying Laryngomalacia, tracheomalacia, macroglossia, micrognathi
Worsening in a supine position Viral or spasmodic croup
Worsening at night Viral or spasmodic croup
Worsening with feeding Croup, bacterial tracheitis
Antecedent upper respiratory tract
infection
Tracheoesophageal fistula, tracheomalacia, neurologic disorder,
vascular compression
Choking Foreign body aspiration, tracheoesophageal fistula
Associated symptoms Possible Aetiology
Barking cough Croup
Brassy cough Tracheal lesion
Drooling Epiglottitis, foreign body in esophagus, retropharyngeal or
peritonsillar abscess
Weak cry Laryngeal anomaly or neuromuscular disorder
Muffled voice Supraglottic lesion
Hoarseness Croup, vocal cord paralysis
Snoring Adenoidal or tonsillar hypertrophy
Past history Possible Aetiology
Intubation trauma Vocal cord paralysis, larynogotracheal stenosis
Birth trauma Vocal cord paralysis
Birth marks Hemangioma
Atopy Angioneurotic edema, spasmodic croup
Family history
Down syndrome
Hypothyroidism
PHYSICAL EXAMINATION
General Possible Aetiology
Cyanosis Cardiac disorder, hypoventilation with hypoxia
Fever Underlying infection
Toxicity Epiglottitis
Tachycardia Cardiac failure
Bradycardia Hypothyroidism
Quality of stridor
Inspiratory Extrathoracic obstruction from supraglottis
Expiratory Obstruction in thoracic trachea or primary or secondary bronchi
Biphasic obstruction in glottis or subglottis or cervical trachea
Position of child Possible Aetiology
Hyperextension of neck Extrinsic obstruction at or above larynx
Leaning over and drooling Epiglottitis
Lessening of stridor on prone Laryngomalacia, micrognathia, macroglossia
Chest finding
Prolonged inspiratory phase Laryngeal obstruction
Prolonged expiratory phase Tracheal obstruction
U/L decreases air entry Foreign body in ipsilateral bronchus
Associated signs
Arrhythmias, murmur, abnormal
heart sound
Structural heart disease
Cutaneous heamangiomas Subglottic haemangioma
Peripheral neuropathy Vocal cord paralysis
Utricaria/ angioedema Angioneurotic oedema
INVESTIGATIONS
I.) Pre-endoscopic
 ABG respiratory acidosis
 Imaging
 A) plain chest x-ray 
 Ground glass appearance  bronchopulmonary dysplasia
 Mediastinal shift/ obstructive emphysema  FB bronchus
 B) Videofluroscopy
 Young children with suspected FB
 Tracheomalacia
 C) Bronchography
 Tracheobronchial stenosis
 Tracheobronchial malacia
 D) USG of vocal cord
 TVC palsy
 E) 24 hr oesophageal pH probe monitoring
 GERD
 F) PFT using flow-volume-loops
 To localize site of obstruction
II.) Endoscopy
 Confirm the diagnosis
 1) Flexible endoscopy in ward/OPD
 Without anaethesia
 Per-oral Vs transnasal
 Screening
 Miss second pathology
 Dynamic abnormalities like laryngomalacia, TVC palsy
 2) Laryngotracheobronchoscopy (LTB)
 Gold standard
 Team work
 Anesthesia
 iv induction
 intubation
 jet ventilation–short pulses of injected anesthetic gas
 laryngeal mask
 Maintenance of anaesthesia  O2 + halothane
 3) Microlaryngotracheobronchoscopy (MLTB)
 With microscope/ rigid telescope
 Microscope (400 mm lens) +/-
 Hopkins rod telescopes
 Age appropriate bronchoscopes
 Laryngeal examination
 ET tube removed
 Superior view
 Mobility of cricoarytenoid joint assessed
 Post, laryngeal cleft
 4.) Bronchoscopy
 Ventilating bronchoscope
 Age-appropriate bronchoscope
 Main bronchi, carina, trachea & subglottis examined
systemically
 Tracheomalacia  use small bronchoscope
Avoid +ve pressure to avoid splinting
 5.) Dynamic assessment of larynx on recovery from
anesthesia
 Assess while withdrawing bronchoscope to just posterior to tip of the
epiglottis
 Advantage:-
 Look cord mobility
 Posterior type of laryngomalacia
 Disadvantage
 Miss ant. collapse of epiglottis
sleep_apnea_n_stidor in otorhinolaryngology.pptx

sleep_apnea_n_stidor in otorhinolaryngology.pptx

  • 1.
    SLEEP APNOEA &STRIDOR DR. NEERAJ RAUNIYAR MS ENT RESIDENT, 3rd YEAR GMSMA For ENT – H & N STUDIES MMC, TUTH, IOM
  • 2.
    SLEEP PHYSIOLOGY  Sleep temporary state of unconsciousness that can be interrupted by external stimuli  Stages of sleep  Quiet/Non rapid eye movement sleep ( non-REM)  Active/Rapid eye movement sleep (REM)  Non-REM sleep  4 stages  Stage 1,2  EEG wave is low voltage & mixed frequency  Stage 3,4  high voltage & slow frequency so caleed Slow Wave Sleep (SWS)  Stage 2 account for ½ of adult sleep.
  • 3.
     REM speep Low voltage & high frequency  2 pattern  Tonic REM  depressed muscle tone  Phasic REM  rapid eye movement & twitching of face & limbs  Dream, increased autonomic activity, fluctuation in BP, pulse, RR  in sleep  1st REM occur  after 90 min of onset of sleep  REM account 25% of sleep  As sleep progresses REM increase & non-REM shortened
  • 4.
     Reticular activatingsystem  promotes wakefulness when active & promotes sleep when inactive.  Neurotransmitters in sleep  Amines  Amino acids  Peptides  Melatonin  released in darkness & promotes sleep 
  • 5.
    SLEEP & RESPIRATION Respiratory centre  in medulla  Afferent  central chemoreceptor sensitive to ph  Peripharal chemoreceptor sensitive to P02  Mechanoreceptor in airway, lungs & chest wall  Efferent  phrenic nerve, peripheral nerve, respiratory muscle  In non-Rem sleep  no diaphragmatic activity & increased intercostal activity  In REM sleep  increased diaphragmatic activity & decreased intercostal activity
  • 6.
     Reduction ofmetabolic rate by 10-25% during sleep due to inhibition of motoe activity & decreased body temp.  Upper airway muscle activity decreases during sleep with associated increase in upper airway resistance predisposing to partial upper airway obstruction  Snoring  low frequency sound produced by vibration of upper airway walls (esp. soft palate) during partial upper airway obstruction
  • 7.
    SLEEP DISORDERS  Respiratorysleep disorder  Obstructive sleep apnoae/hypopnoae (OSAH)  Central sleep apnoae/hypopnoae  Cheyne- Stokrs breathing  Sleep hypoventilation  Non- respiratory sleep disorder  Narcolepsy  Periodic limb movement disorder  Idiopathic hypersomnia
  • 8.
    OBSTRUCTIVE SLEEP APNOAE/HYPOPNOAE (OSAH) Recurrent episodes of partial or complete upper airway obstruction during sleep which are usually terminated by an arousal
  • 9.
    CAUSES Congenital  Nasal obstruction b/l choanal atresia  Neonatal rhinitis  Congenital cyst of nasal cavity  Facial skeletal abnormalities  Nasopharyngeal airway obstruction  Apert’s ,Crouzon’s syndrome  Oropharyngeal obstruction  Treacher Collins syndrome  Pierre Robin syndrome  Macroglossia  Down’s syndrome, Beckwith syndrome, cystic hygroma  Pharyngeal swelling  Lingual thyroid mass  Lingual thyroglossal duct  Cong tumors of pharynx (teratoma, thorwald's cyst)
  • 10.
    Acquired  Traumatic  Inflammatory Adenotonsillar hypertrophy  Nasal polyp, rhinitis  Peri/para/retropharyngeal abscess  Neoplastic  Angiofibroma, neuroblastoma, lymphoma  Iatrogenic  Post tonsillectomy adenoidectomy, PNP  Pharyngeal airway dysfunction  Obesity  Pickwickian syndrome  Chubby puffer syndrome (Stool 1997)
  • 11.
    PATHOGENESIS Sleep decreased upperairway muscle activity upper airway collapse Stimulate increased respiratory effort hypercapnia/ hypoxaemi hypoventilation Arousal resumption of normal upper airway muscle activity relief of upper airway obstruction cycle repeats sleep resumes Correction of hypercapnia/hypoxeamia
  • 12.
  • 13.
    EPIDEMIOLOGY OF OSAH 4 % male and 2% female ( Young et al,. 1993)  Approx. 5% in a given population ( Young et al,. 2002)  More common & severe in male  3-7 yrs of age in children with equal in both sexes  Greater in Chinese origin  Risk factor for OSAH  Obesity  Gender ( male)  Increased age  Sex hormone ( progesterone  increases upper airway dilating muscle activity)  Individual variation in mandibular, tongue & soft palate size and position  Adenotonsillar hypertrophy
  • 14.
     Associated medicalconditions:-  Cardiovascular disease  HTN  CAD  Cerebrovascular disease  Stroke  Metabolic syndrome  Obesity  DM  HTN  Insulin resistance
  • 15.
    SYMPTOMS  Snoring  Fatigue Witnessed breath-holds  Gasping & choking  Excessive daytime sleepiness (EDS)  Fragmented sleep • Unrefreshing sleep • Reduced alertness • Mood changes • Nocturia • Impaired work performance • H/O DM, HTN, Hypertriglyceridaemai In children • Failure to thrive • Sweet during sleep • Unusual sleeping position • Tracheal tug • Hyperactivity Vs EDS in adult
  • 16.
    EXAMINATION  Central obesity BMI > 28  Neck circumference > 47 cm (have predictive value)  Detailed nasal & oropharyngeal examination including  Mallampati score  Retrognathia  Craniofacial abnormality  Adenotonsillar hypertrophy  History & examination has sensitivity & specificity of 50% only (Hoffstein et al,. 1993)  EDS measured with Epworth Sleepiness Scale (ESS) ???????put scoring table
  • 17.
    THE EPWORTH SLEEPINESSSCALE Score situation  Sitting and reading  Watching TV  Sitting inactive in a public place (eg, theater, meeting)  As a passenger in a car for an hour without break  Lying down to rest in the afternoon when circumstances permit  Sitting and talking to someone  Sitting quietly after a lunch without alcohol  In a car, while stopped for a few minutes in the traffic Normal score 2-10 Mod – severe OSA > 16 0 - Would never doze off 1 - Slight chance of dozing off 2 - Moderate chance of dozing off 3 - High chance of dozing off
  • 18.
    INVESTIGATIONS  Videondoscopy  Polysomnography Sleep nasendoscopy +/- Video  Oesopharyngeal manometry  Cephalometry with Mueller manoeuver  Fluroscopy  3D CT  Dynamic ultrafast MRI  Acoustic analysis  Nasal spray test Can identify site of snoring
  • 19.
    SLEEP NASENDOSCOPY-  Cansite of snoring be identified?  Widely used in UK  Procedure-: Sleep Nasendoscopy Grading Grade Obstruction 1 Simple palatal level snoring/palatal flutter 2 Single level palatal obstruction 3 Palatal level obstruction with intermittent oropharyngeal involvement 4 Sustained multisegmental obstruction 5 Tongue base obstruction 6 Isolated epiglottic involvement
  • 20.
     Other wayto classify level of obstruction is  level 1  adenoid or valopharyngeal obstruction  Level 2  tonsillar obstruction  Level 3  tongue base obstruction  Level 4  supraglottic obstruction Fig Findings at sleep nasendoscopy. The photographs show the endoscopic view of the obstruction at each level from 1 to 4.
  • 21.
     Polysomnography  EEG EOG  EMG  Overnight oximetry  Domiciliary multichannel testing  Apnoae  complete cessation of airflow for al least 10 sec. regardless of where there is associated o2 desaturation or aurosal.  In children its 6 sec duration  Hypoapnoae  reduction in airflow of 50 – 90%with or without =/>3% o2 desaturation &/or EEG changes OR reduction in airflow of <50% accompanied by =/>3% o2 desaturation &/or EEG changes
  • 22.
    OVERNIGHT OXIMETRY  Measureo2 saturation & pulse rate  >97% SpO2  excludes hpoxia/ hpercarbia  < 87% SpO2  coexistient cardiac or broncho-pulmonary disease  Principle  when apnoea/hypoanoae 02 saturation falls & when apnoae/hyponoae relieved o2 saturation recovered  Rise & falls in 02 saturation  o2 dip  A dip of fall in o2 saturation of 4%  significant  O2 desaturation index (ODI)  no. of times of o2 saturation falls by 4% averaged our per hr
  • 23.
     A ODIof > 15/hr OSA  Other features in diagnosis of OSA are  ESS > 10  BMI > 28kg/m2  Co-morbidities  HTN  CAD  DM  Metabolic syndrome  O2 saturation monitored with wristwatch device which pt. wear at night  It’s a screening tool which has good specificity but lack sensitivity  It may miss OSA who do not desaturate
  • 24.
    HOME MULTICHANNEL TESTING Usually consist of oronasal cannulae, thoracic & abdominal band & finger oximeter probe  Thoracic & abdominal band  determine type of upper airway obstruction  OSAH chest & abdominal band display movement  Central Sleep apnoae/hypoapnoae  no chest & abdominal movement  Advantages-  Pt. comfort  Cost saving  Prevention of hosp. admission  Rapid analysis of data
  • 25.
     Disadvantages-  Sensorfailure  Loss of signal A classic example of OSA with repetitive apnoeas. X-axis is five minutes. 1st - trace is the oronasal cannulae flow, 2nd - thoracic band, 3rd - abdominal band, 4th - trace is oxygenation and 5th - is pulse rate.
  • 26.
    POLYSOMNOGRAPHY  Gold standard Sleep state  EEG  EOG  EMG  Respiratory variables  O2 saturation  Oronasal airflow  Chest & abd movement  Tracheal microphone  Oesophageal balloon manometer  Non respiratory variable  ECG  Anterior tibialis EMG  Sleeping position detector  Video monitoring
  • 27.
     Values calculated Apnea/hypoanoae index(AHI)  Mild OSA = 5-20 / hour.  Moderate OSA = 20-40 / hour.  Severe OSA = >40 / per hour  Apnea type  Apnea duration  Degree of O2 saturation  Time spent at each level of desaturation
  • 28.
    OVERNIGHT POLYSOMNOGRAPHY  Indication- Complex OSA such as OHS  Neuromuscular disorder which need ventilatory support  Narcolepsy  Periodic leg movement syndrome
  • 29.
    OESOPHAGEAL MANOMETRY  Usedwith sleep screening studies  To diagnose apnoae/hypoapnoae  Also used to evaluate relationship between reflux & OSA C) Ultrafast MRI  Used in awake and asleep pt.  Also used to quantify surgical tissue volume resection to achieve resolution of snoring
  • 30.
    3D COMPUTERIZED TOMOGRAPHTY Esp. imp to evaluate retropalatal space
  • 31.
    CEPHALOMETRY  Esp forpt. undergoing UPPP & MAS
  • 32.
    NASAL SPAY TEST Decongestant on alternate night compare severity of snoring & apnoae treat nasal pathology Improvement in symptoms
  • 33.
     Which testshould be used?  Oximetry as 1st line screening  in borderline/ uncertain cases PSG
  • 34.
     Apnoae/hypoapnoae index(AHI)  no. of apnoae/hypoapnoae averaged per hr. American Apnoae Association grading of sleep apnoae AHI Level of OSA < 5 No OSA 5-20 Mild 20-40 Moderate > 40 Severe
  • 35.
    TREATMENT  When totreat?  OSA without EDS &/or co-morbidity as HTN, DM, CAD  no treatment Lifestyle modification like reducing wt. particularly if BMI > 25 kg/m2 & treating any co-morbidity  Mils OSA with EDS &/or co-morbidity as HTN, DM, CAD  Moderate/ Severe OSA with/ without EDS & co-morbidity  Treatment  A) medical  B) Surgical Need treatment
  • 36.
     Medical management Exclude hypothyroidism/ acromegaly  Alcohol advice  Drug review  Weight loss  Nasal medication  Nosovent  Drugs  Protryptyline  Acetazolamide, theophylline, doxapram, buspirone, nocotine
  • 37.
    MEDICAL TREATMENT 1.) Continuouspositive airway pressure (CPAP)  Acts as pneumatic splint  MOA blowing air through a tube & mask through nasal &/or oral passageway will support pharyngeal & palatal walls thus preventing collapse of airway  The equipment  Fixed pressure CPAP  constant blowing pressure  Auto CPAP  vary pressure depending on presence of apnoae/hypoapnoae  Predicted pressure for CPAP ( cm H2O) = (0.16 x BMI) + ( 0.13 x NC) + (0.04 x AHI) -5.12 Where NC = neck circumference Used in children who are syndromic, obese, CP
  • 38.
     S/E ofCPAP  Claustrophobia  Nasal stuffiness  Leaks  Coryzal illness  Skin abrasions  Ulceration of bride of nose  Air swallowing  Pulmonary barotrauma
  • 39.
     Treatment Failure Mainly due to poor tolerance to CPAP  Lead to continued symptoms + risk of co-morbidity esp. cardiovascular, cerebrovascular & DM  Compliance & Troubleshooting  By 3 yr, 12-25%  discontinued CPAP  Compliance increased  =/>4 hrs of using CPAP for at least 5 nights/weeks  Close f/u  Adequate education abt. CPAP  Consequences of not treating OSA Influence long-term use of CPAP
  • 40.
    2.) Nasopharyngeal airway:- In new born & few days old baby  Length adjusted acc. to site of obstruction  e.g. in Pierre Robin sequence  lies just above epiglottis  In Apart Syndrome  free edge of soft palate 3.) Mandibular Advancement Splint (MAS):-  Not tolerate CPAP  Not fit for surgery
  • 41.
    NEW TREATMENT  inspire®Upper Airway Stimulation (UAS) therapy is a new treatment option for obstructive sleep apnea patients who are unable to use Continuous Positive Airway Pressure (CPAP)  Inspire is a fully implanted system that is designed to sense breathing patterns and deliver mild stimulation to a patient’s airway muscles to keep the airway open during sleep.
  • 42.
    MULLER MANOEVER Scoring system( Sher et al 1985) Degree of pharyngeal obstruction at each level  1+ minimal collapse  2+ collapse decreasing cross section area by 50%  3+ collapse decreasing cross section area by 75%  4 + obliteration of the airway Soft palate level lower pharyng level UPPP 3+ 4+ - ideal 3+ 4+ 1+2+ suboptimal <3+ > 2+ not suitable
  • 43.
     Indication forsurgery:-  Patient with severe antisocial snoring  Without OSA  Localized obstruction at one level in upper airway usually at palatal level  Multisegmental obstruction with predominant obs. at palatal level  Patient with mild-to-moderate sleep apnoae  With severe antisocial snoring  Failed or inadequate response to CPAP  Localized obstruction at one level in upper airway usually at palatal level  Patients with moderate-to-severe sleep apnoae  With severe antisocial snoring  Failed or inadequate response to CPAP  Multisegmental obstruction RFTVR LAUP UPPP Combination of procedure on Palate Tongue base Lateral pharyngeal walls
  • 44.
    SURGICAL TREATMENT  A)Adenotonsillectomy :  Treatment of choice in children  Treatment acc. To level of obstruction :-  Level 1  adenoidectomy  Level 2  tonsillectomy  Level 3  nasopharyngeal airways, glossopexy, MAS, CPAP  Level 4  LASER supraglottoplasty, anterior epiglottopexy
  • 45.
    SURGICAL TECHNIQUE  B)Uvulopalatopharyngoplasty  Resection of a strip of soft palate & uvula in combination with tonsillectomy  tonsillar pillar sutured together  Principle to stiffen the soft palate by scarring and to increase space behind the soft palate to minimize obstruction  Complication:-  Severe post-op pain  Haemorrage (2-14%)  Airway obstruction  Post-op pulmonary oedema & hypoxia(2-11%)  Nasal regurgitation (13%)
  • 46.
     valopharyngeal stenosis Dry throat  Excessive pharyngeal hypersecretion (10%)  Swallowing problems (9%)  Voice changes (7%)  Taste disturbance  Short tern success rate  76-95%  Long term success rate  45% (Hicklin et al,. 2000)
  • 47.
     C) Laser-assisteduvulopalatoplasty (LAUP)  OPD procedure & done under local anaesthesia  Principle  stiffen the soft palate and thereby minimize snoring due to palatal flutter  Procedure  Bilateral vertical incisions are made in the soft palate followed by partial vaporization of the uvula with a CO2 laser after giving local inj.  Adv.  no post-op nasal regurgitation  Disadv.  1-5 procedure 1 month apart to complete treatment
  • 48.
     Complication:-  Comparativelyless than UPPP bt depend on degree of vaporization  Globus type sensation  Post-op pain  Fungal infection  Short tern success rate  79%  Long term success rate  55% (Berger et al,. 2001)
  • 49.
     D) RadiofrequencyTissue Volume Reduction (RFTVR)/ Thermal ablation  Principle  thermal injury to specific submucosal sites in the soft palate resulting in fibrosis of the muscular layer and volumetric tissue reduction  Advantages:-  Day care surgery under local  Less post-op pain  Less other complication
  • 50.
     Complications:-  Ulcerof tongue base & soft palate  Dysphagia  Temporary CN XII palsy  Abscess at tongue base  Short tern success rate  50-85% (Johnson et al,. 2002)  Long term success rate  52% (Said et al,. 2003)  Recent advances in treatment in RFTVR  Somnus device  Celon device  bipolar electrode tip so reduced procedure time  Coblater unit  larger electrode tip so more complication
  • 51.
    NASAL OBSTRUCTION ANDNASAL SURGERY IN THE PATHOGENESIS AND TREATMENT OF SNORING AND OBSTRUCTIVE SLEEP APNOEA  Exact role unclear  reduced nasal cross-sectional area promotes increased nasal resistance to airflow and promotes inspiratory collapse of both the oro­and hypopharynx  If nasal obstruction contributes to OSA development, correction of the obstructed airway should improve OSA but its not the case in most of OSA
  • 52.
    OCCASIONAL PROCEDURES FORSNORING AND OBSTRUCTIVE SLEEP APNOEA  Injection snoroplasty technique  Outpatient uvulopalatal flap  Palatal inplants  Repose tongue base suspension suture  Mandibular Advancement Surgery (MVS)  Brings tongue base forwards thus increasing dimension of upper airway  Adv.   simplicity  Reversibility  Cost effectiveness
  • 53.
    FOLLOW UP  Aimto  Determine compliance  Minimize intolerance  Improve symptoms  Continue to modify cardiovascular risk factor  Some centre uses repeat overnight oximetry with CPAP
  • 54.
    CENTRAL SLEEP APNOEA Causes Ondine’s curse  Altitude  Cheyne-Stokes respiration  Congestive heart failure  Myxoedema  Neurological lesions  Brainstem infarct, encephalitis  Bulbar poliomyelitis  Supratentorial space-occupying lesions Treatment  Medical therapy  Theophylline  Ventilation via tracheostomy  Diaphragm pacing with implanted b/l phrenic nerve electrodes
  • 55.
    STRIDOR  Stridor noisy sound of high pitch generated from turbulence of airflow in larynx & trachea.  Stertor  low pitch snoring type of noise produced by obstruction of naso & oropharynx  Characteristics of stridor  Inspiratory  extrathoracic obstruction from supraglottis  Expiratory  obstruction in thoracic trachea or primary or secondary bronchi  Biphasic obstruction in glottis or subglottis or cervical trachea  Bernoulli law – velocity increases, pressure decreases – collapse of airway  Pascal’s principle – pressure same at every point on containing walls Type of stridor n site of origin
  • 56.
    CAUSES OF STRIDOR Larynx Congenital 1.Laryngomalacia 2.Subglotticstenosis 3.Webs, cyst, laryngocele Inflammatory 4.Croup 5.Epiglottitis 6.Angioneurotic oedema 7.Diphtheria 8.Fungal infections 9.Tuberculosis Vocal cord paralysis 1. Nerve damage, post thyroidectomy Trauma 2. Intubation 3. Neck trauma 4. FB Neoplasam 5. Benign –subglottic hemangioma, laryngeal papilloma, lymphangioma 6. Malignant – Ca larynx Laryngospasm
  • 57.
    Trachea & bronchi Congenital 1.Vascular anomalies 2. Webs, cysts 3. Tracheal stenosis 4. Tracheoesophageal fistula Inflammatory 5. Tracheitis 6. Bronchitis 7. Cruop FB 1.Esophageal 2.Tracheal/bronchial Neoplasm 3.Tracheal 4.Extraluminal 1.Thyroid 2.Esophageal 3.Thymus Trauma
  • 58.
     Lesion outsiderespiratory tract  Congenital: Vascular rings, oesophageal atresia, tracheo- oesophageal fistula, cystic hygroma.  Inflammatory: Retropharyngeal and retro-oesophageal abscess .  Traumatic: FB oesophagus (secondary tracheal compresssion) .  Tumours: Masses in neck
  • 59.
    Age of onsetPossible Aetiology Birth Vocal cord paralysis choanal atresia, laryngeal web, vascular ring 4-6 weeks Laryngomalacia 1-4 years Croup, epiglottitis, foreign body aspiration Chronicity Acute Foreign body aspiration, croup, epiglottitis, retropharyngeal abscess chronic Structural lesion laryngomalacia, laryngeal web or larynogotracheal stenosis ASSESSMENT
  • 60.
    Precipitating Factors PossibleAetiology Worsening with straining or crying Laryngomalacia, tracheomalacia, macroglossia, micrognathi Worsening in a supine position Viral or spasmodic croup Worsening at night Viral or spasmodic croup Worsening with feeding Croup, bacterial tracheitis Antecedent upper respiratory tract infection Tracheoesophageal fistula, tracheomalacia, neurologic disorder, vascular compression Choking Foreign body aspiration, tracheoesophageal fistula
  • 61.
    Associated symptoms PossibleAetiology Barking cough Croup Brassy cough Tracheal lesion Drooling Epiglottitis, foreign body in esophagus, retropharyngeal or peritonsillar abscess Weak cry Laryngeal anomaly or neuromuscular disorder Muffled voice Supraglottic lesion Hoarseness Croup, vocal cord paralysis Snoring Adenoidal or tonsillar hypertrophy
  • 62.
    Past history PossibleAetiology Intubation trauma Vocal cord paralysis, larynogotracheal stenosis Birth trauma Vocal cord paralysis Birth marks Hemangioma Atopy Angioneurotic edema, spasmodic croup Family history Down syndrome Hypothyroidism
  • 63.
    PHYSICAL EXAMINATION General PossibleAetiology Cyanosis Cardiac disorder, hypoventilation with hypoxia Fever Underlying infection Toxicity Epiglottitis Tachycardia Cardiac failure Bradycardia Hypothyroidism Quality of stridor Inspiratory Extrathoracic obstruction from supraglottis Expiratory Obstruction in thoracic trachea or primary or secondary bronchi Biphasic obstruction in glottis or subglottis or cervical trachea
  • 64.
    Position of childPossible Aetiology Hyperextension of neck Extrinsic obstruction at or above larynx Leaning over and drooling Epiglottitis Lessening of stridor on prone Laryngomalacia, micrognathia, macroglossia Chest finding Prolonged inspiratory phase Laryngeal obstruction Prolonged expiratory phase Tracheal obstruction U/L decreases air entry Foreign body in ipsilateral bronchus Associated signs Arrhythmias, murmur, abnormal heart sound Structural heart disease Cutaneous heamangiomas Subglottic haemangioma Peripheral neuropathy Vocal cord paralysis Utricaria/ angioedema Angioneurotic oedema
  • 65.
    INVESTIGATIONS I.) Pre-endoscopic  ABGrespiratory acidosis  Imaging  A) plain chest x-ray   Ground glass appearance  bronchopulmonary dysplasia  Mediastinal shift/ obstructive emphysema  FB bronchus  B) Videofluroscopy  Young children with suspected FB  Tracheomalacia  C) Bronchography  Tracheobronchial stenosis  Tracheobronchial malacia
  • 66.
     D) USGof vocal cord  TVC palsy  E) 24 hr oesophageal pH probe monitoring  GERD  F) PFT using flow-volume-loops  To localize site of obstruction
  • 67.
    II.) Endoscopy  Confirmthe diagnosis  1) Flexible endoscopy in ward/OPD  Without anaethesia  Per-oral Vs transnasal  Screening  Miss second pathology  Dynamic abnormalities like laryngomalacia, TVC palsy
  • 68.
     2) Laryngotracheobronchoscopy(LTB)  Gold standard  Team work  Anesthesia  iv induction  intubation  jet ventilation–short pulses of injected anesthetic gas  laryngeal mask  Maintenance of anaesthesia  O2 + halothane
  • 69.
     3) Microlaryngotracheobronchoscopy(MLTB)  With microscope/ rigid telescope  Microscope (400 mm lens) +/-  Hopkins rod telescopes  Age appropriate bronchoscopes  Laryngeal examination  ET tube removed  Superior view  Mobility of cricoarytenoid joint assessed  Post, laryngeal cleft
  • 70.
     4.) Bronchoscopy Ventilating bronchoscope  Age-appropriate bronchoscope  Main bronchi, carina, trachea & subglottis examined systemically  Tracheomalacia  use small bronchoscope Avoid +ve pressure to avoid splinting
  • 71.
     5.) Dynamicassessment of larynx on recovery from anesthesia  Assess while withdrawing bronchoscope to just posterior to tip of the epiglottis  Advantage:-  Look cord mobility  Posterior type of laryngomalacia  Disadvantage  Miss ant. collapse of epiglottis

Editor's Notes

  • #6 Other sites of vibration  tonsil, epiglottis, base of tongue
  • #21 Since history n examination has poor sensitivity n specificity other tools used to diagnose OSAH
  • #24 Oronasal canulae nasal or nasal air flow Thoracic/ abd. Band  measure chest or abd. movenent
  • #25 A classic example of OSA with repetitive apnoeas. X-axis is five minutes. The top trace is the oronasal cannulae flow, the second the thoracic band, the third the abdomi nal band, the fourth trace is oxygenation and the fifth is pulse rate. Note the marked desaturations of oxygen with each apnoea, which recovers once the apnoea has ended, and because of lag time effect, the nadir of oxygen saturation always follows the apnoea
  • #27 Minisleep study
  • #34 No. apnoae/hypoapnoae divided by total sleep time  AHI
  • #37 No significant difference betn fixed or (Sullivan et al 1981 auto CPAP
  • #45 Described by Ikemastu in 1950s n popularized by Fugita in 1985
  • #47 By kamami in france in 1993 Lignocaine with adrenaline is injected above the base of the uvula and 1 cm lateral to the midline in the inferior portion of the soft palate. Bilateral vertical incisions are made in the soft palate followed by partial vaporization of the uvula with a CO2 laser.
  • #49 RFTVR  treatment of choice now
  • #59 History Perinatal history Birth  laryngeal web, subglottic stenosis After 1st few weeks  congenital vocal cord palsy Pattern od stridor Laryngomalacia  better with siting, prone and asleep but worse with cry, feed and when distress Associated feature
  • #68 Iv induction  for older child, preop steroid, atopine for dry surgical field, gus for infant Intubation  quickly ventilated to level so that endoscope passed without gag n maintain spontaneous resp. Jet ventilation  child paralyzed, gas exchange maintained with short pulse of iv anaesthetic , s/e pneumothorax in neonates Laryngeal mask  in difficult intubation n mandibular hypoplasia, also 4 fibre optic bronchoscopy
  • #71 Excellent technique  use fibre optic bronchoscope with laryngeal mask ventilation just above laryngeal inlet